Physician profile
Leah John
NPI 1932529195
$16,607.18
in general payments reported to CMS, 2019-2025
7 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,772 · 2020: $1,229 · 2021: $6,304 · 2022: $226 · 2023: $4,263 · 2024: $1,672 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,277 · Food and Beverage: $2,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,276.97 |
| Food and Beverage | $2,798.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,995.17 | 2019-2025 | Ensite Precision, Ensite, Gallant |
| Medtronic, INC. | $4,627.18 | 2021-2023 | Micra |
| Biotronik INC. | $2,133.53 | 2021-2023 | Plexa Promri, Acticor 7 Vr-T Dx |
| Medical Device Business Services, INC. | $1,480.00 | 2024 | Carto 3 |
| Biosense Webster, INC. | $1,103.36 | 2024-2025 | Carto 3, Na, Soundstar |
| Boston Scientific Corporation | $148.94 | 2019 | |
| Medtronic Vascular, INC. | $119.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.